Page 159 - CW E-Magazine (16-4-2024)

Pharmaceuticals

ACCELERATED GROWTH
Sanofi to fast-track product pipeline in India

Aiming for a “fair share” in the
Indian pharmaceutical market, French
drug major Sanofi plans to introduce
new drugs and enhance localisation
while expanding the reach of its exist-
ing brands through collaboration with
domestic drug fi rms, according to a top
company offi cial.

The company plans to enhance its
presence in the diabetes segment and
grow its consumer healthcare business
after spinning it off into a new entity,
while also looking at local production opportunity right now and in the future noted that diabetes is a big focus area for
of its various best-in-class products in as well. The potential of this market is the company. “Diabetes is a big unsolved
India. phenomenal,” he said. “We are seek- problem in India. It is one of the priorities
ing the route to be better represented ... for Sanofi to continue to cater to therapies
In an interaction with PTI, Sanofi with a fair share of the Indian pharma- for diabetes in India,” he said.
India managing director Mr. Rodolfo ceutical market.”
Hrosz stated that the company has With Soliqua, the company will
embarked on a mission to prepare for an Terming India as a very important enter into the premix insulin segment
accelerated growth path in the country. market, Mr. Hrosz said the company allowing physicians to provide more
“We believe we are underrepresented sees immense potential for growth in tailored options for better diabetes
(in India) and we see a signifi cant the country over the next few years. He management, he added.

Lupin appoints Dr. Ranjana Pathak as Chief Quality
Offi cer

Lupin has announced the appoint-
ment of Dr. Ranjana Pathak as Chief
Quality Offi cer, succeeding Johnny
Mikell who will be retiring from the
services of the company. With over
three decades of industry experience,
Dr. Pathak brings a wealth of expertise
and leadership and will oversee all as-
pects of quality and regulatory compli-
ance for Lupin’s global operations.

Dr. Pathak’s career includes serv-
ing as the Global Head for Quality and
Pharmacovigilance at Dr. Reddy’s. Prior
to this, she served as the President
& Global Head of Quality, Medical Cipla and has also held Global Quality Watson/Actavis and Endo Pharmaceu-
Affairs and Pharmacovigilance at and Compliance leadership positions at ticals in the US.

Chemical Weekly April 16, 2024 159

Contents Index to Advertisers Index to Products Advertised